Humira generic availability, cost, and dosage
The Checkup by Singlecare
MARCH 8, 2024
Hulio (adalimumab-fkjp) Hulio was approved by the FDA in July 2020 and became available in the United States in July 2023. The warning states that because adalimumab products affect the immune system, there is an increased risk of serious infections that can lead to hospitalization or death. Biocon Biologics makes this biosimilar.
Let's personalize your content